Monopar Therapeutics Inc. (MNPR) Ownership

$36.25

$1.09 (3.1%)
Last update: 01:00 PM EST
Day's range
$34.91
Day's range
$36.25

Monopar Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 05/15/2025 1.13 M $45.60 M   8.36% 1.62%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 599.20 K $21.82 M   0.00% 0.86%
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 511.21 K $18.61 M   0.00% 0.73%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 168.16 K $6.12 M   0.16% 0.24%
ADAR1 CAPITAL MANAGEMENT, LLC 05/15/2025 100.77 K $3.67 M   -22.50% 0.14%
AFFINITY ASSET ADVISORS, LLC 05/14/2025 62.00 K $2.26 M   100.00% 0.09%
MILLENNIUM MANAGEMENT LLC 05/15/2025 60.37 K $2.20 M   100.00% 0.09%
VANGUARD GROUP INC 05/09/2025 55.23 K $2.01 M   -2.26% 0.08%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 48.54 K $1.77 M   25.76% 0.07%
MARSHALL WACE, LLP 05/15/2025 25.99 K $946.22 K   100.00% 0.04%
GOLDMAN SACHS GROUP INC 06/27/2025 18.48 K $672.86 K   100.00% 0.03%
STATE STREET CORP 05/15/2025 15.81 K $575.79 K   100.00% 0.02%
BLACKROCK, INC. 05/02/2025 14.46 K $526.64 K   78.55% 0.02%
JANE STREET GROUP, LLC 05/19/2025 10.36 K $377.10 K   100.00% 0.01%
NORTHERN TRUST CORP 05/13/2025 9.16 K $333.55 K   100.00% 0.01%
OMERS ADMINISTRATION CORP 05/14/2025 9.00 K $327.69 K   100.00% 0.01%
HRT FINANCIAL LP 05/15/2025 8.23 K $299.00 K   100.00% 0.01%
UBS GROUP AG 05/13/2025 8.12 K $295.69 K   26.44% 0.01%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 6.14 K $223.59 K   100.00% 0.01%
IKARIAN CAPITAL, LLC 05/15/2025 5.91 K $215.11 K   0.00% 0.01%
GERBER, LLC 04/23/2025 5.60 K $203.93 K   100.00% 0.01%
BANK OF AMERICA CORP /DE/ 05/15/2025 2.48 K $90.22 K   8,750.00% 0.00%
POINT72 ASIA (SINGAPORE) PTE. LTD. 05/15/2025 1.76 K $64.11 K   100.00% 0.00%
MORGAN STANLEY 05/15/2025 1.42 K $51.85 K   -62.54% 0.00%
QUEST PARTNERS LLC 05/14/2025 1.22 K $44.24 K   100.00% 0.00%
NEWEDGE ADVISORS, LLC 05/15/2025 600 $21.85 K   0.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 303 $11.03 K   -56.47% 0.00%
WELLS FARGO & COMPANY/MN 05/13/2025 250 $9.10 K   0.00% 0.00%
CITIGROUP INC 05/12/2025 225 $8.19 K   100.00% 0.00%
ROYAL BANK OF CANADA 05/15/2025 205 $7.00 K   100.00% 0.00%
POINT72 (DIFC) LTD 05/15/2025 196 $7.13 K   100.00% 0.00%
ALLWORTH FINANCIAL LP 04/30/2025 100 $4.46 K   100.00% 0.00%
JPMORGAN CHASE & CO 05/12/2025 100 $3.64 K   -95.09% 0.00%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 05/15/2025 16 $583   0.00% 0.00%
05/02/2025 0 $0   -100.00% 0.00%

Monopar Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 36 institutional investors and hedge funds held shares of Monopar Therapeutics Inc.. The most heavily invested institutionals were:

JANUS HENDERSON GROUP PLC: 1.13 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 599,195

RA CAPITAL MANAGEMENT, L.P.: 511,207

Point72 Asset Management, L.P.: 168,160

ADAR1 Capital Management, LLC: 100,774

Affinity Asset Advisors, LLC: 62,000

4.13% of Monopar Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 2.89 M shares in the last 24 months. This purchase volume represents approximately $104.62 M in transactions.